Suzhou Zelgen Biopharmaceuticals

Suzhou Zelgen Biopharmaceuticals

Suzhou Zelgen Biopharmaceuticals

Zelgen is focused on cancer, hematology and auto-immune products.
Founded
2009
Raised
$61.3M
Follow us
Alexa global traffic share
Latest funding
CNY ¥400,000,000
Venture capital (Series B) - 2018
Shenzhen Capital Group Share Capital Minsheng Life Insurance
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Suzhou Zelgen Biopharmaceuticals makes some noise.